NYSE:AVNS - Avanos Medical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $44.33
  • Forecasted Upside: 37.04 %
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$32.35
▲ +0.2 (0.62%)

This chart shows the closing price for AVNS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Avanos Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVNS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVNS

Analyst Price Target is $44.33
▲ +37.04% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Avanos Medical in the last 3 months. The average price target is $44.33, with a high forecast of $47.00 and a low forecast of $41.00. The average price target represents a 37.04% upside from the last price of $32.35.

This chart shows the closing price for AVNS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Avanos Medical. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
4/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2021Morgan StanleyLower Price TargetUnderweight$45.00 ➝ $41.00High
8/4/2021KeyCorpLower Price TargetOverweight$55.00 ➝ $47.00High
8/4/2021StephensDowngradeOverweight ➝ Equal Weight$60.00 ➝ $45.00High
1/8/2021KeyCorpBoost Price TargetOverweight$47.00 ➝ $55.00Low
12/15/2020Morgan StanleyBoost Price TargetUnderweight$36.00 ➝ $45.00Medium
11/4/2020Morgan StanleyBoost Price TargetUnderweight$31.00 ➝ $36.00Low
11/4/2020KeyCorpBoost Price TargetOverweight$43.00 ➝ $47.00Low
8/5/2020KeyCorpLower Price TargetOverweight$45.00 ➝ $43.00High
5/7/2020Morgan StanleyBoost Price TargetUnderweight$29.00 ➝ $31.00High
4/27/2020KeyCorpLower Price TargetOverweight$48.00 ➝ $45.00High
4/13/2020BarclaysUpgradeUnderweight ➝ Equal Weight$30.00Medium
4/1/2020Stifel NicolausLower Price TargetHold$35.00 ➝ $32.00High
3/27/2020Morgan StanleyLower Price TargetSell$32.00 ➝ $29.00Low
3/23/2020StephensLower Price TargetOverweight$40.00 ➝ $30.00High
2/27/2020BarclaysReiterated RatingSell$32.00Medium
1/28/2020BarclaysReiterated RatingSell$30.00Low
12/17/2019Morgan StanleyLower Price TargetUnderweight$36.00 ➝ $32.00High
11/6/2019Stifel NicolausDowngradeBuy ➝ Hold$45.00 ➝ $35.00Low
11/6/2019Raymond JamesDowngradeOutperform ➝ Market PerformHigh
8/21/2019JMP SecuritiesReiterated RatingHoldN/A
8/7/2019Stifel NicolausSet Price TargetBuy$45.00Low
8/7/2019Raymond JamesLower Price TargetOutperform$57.00 ➝ $48.00Medium
5/8/2019Morgan StanleySet Price TargetSell$47.00Low
2/27/2019KeyCorpLower Price TargetOverweight ➝ Overweight$67.00 ➝ $65.00High
1/4/2019BarclaysDowngradeEqual Weight ➝ UnderweightHigh
12/18/2018KeyCorpLower Price TargetOverweight ➝ Overweight$68.00 ➝ $67.00Low
10/15/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$69.00High
10/11/2018Morgan StanleyBoost Price TargetUnderweight$60.00 ➝ $62.00Low
8/21/2018Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
8/8/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$58.00 ➝ $60.00Medium
8/8/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$66.00 ➝ $75.00High
(Data available from 9/23/2016 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
8/24/2021
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
9/23/2021

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Avanos Medical logo
Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Read More

Today's Range

Now: $32.35
Low: $32.00
High: $32.40

50 Day Range

MA: $33.77
Low: $31.38
High: $38.50

52 Week Range

Now: $32.35
Low: $30.96
High: $53.61

Volume

4,320 shs

Average Volume

364,363 shs

Market Capitalization

$1.56 billion

P/E Ratio

1,078.33

Dividend Yield

N/A

Beta

0.91

Frequently Asked Questions

What sell-side analysts currently cover shares of Avanos Medical?

The following Wall Street analysts have issued stock ratings on Avanos Medical in the last year: KeyCorp, Morgan Stanley, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for AVNS.

What is the current price target for Avanos Medical?

3 Wall Street analysts have set twelve-month price targets for Avanos Medical in the last year. Their average twelve-month price target is $44.33, suggesting a possible upside of 37.0%. KeyCorp has the highest price target set, predicting AVNS will reach $47.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $41.00 for Avanos Medical in the next year.
View the latest price targets for AVNS.

What is the current consensus analyst rating for Avanos Medical?

Avanos Medical currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AVNS, but not buy more shares or sell existing shares.
View the latest ratings for AVNS.

What other companies compete with Avanos Medical?

How do I contact Avanos Medical's investor relations team?

Avanos Medical's physical mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company's listed phone number is (844) 428-2667 and its investor relations email address is [email protected] The official website for Avanos Medical is avanos.com.